Skip Navigation
Department of Health and Human Services www.hhs.gov
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Presentation to Slide Tray Presentation:

Management of Chronic Kidney Disease Stages 1–3

Slide: 23 of 29

Clinical Bottom Line: Screening and Monitoring in Subpopulations

Indirect evidence from the comparative effectiveness review suggests that screening populations at high risk for developing chronic kidney disease (patients with diabetes, hypertension, or cardiovascular disease) and monitoring patients who already have early signs of kidney disease for albuminuria and the estimated glomerular filtration rate may help identify those patients with chronic kidney disease stages 1–3 who might benefit from early initiation of treatment with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and/or statins.